Our findings suggest that a better understanding of the regulation and function of AR expression in stromal myofibroblasts, and of the interactions between the cancer cells and stromal myofibroblasts, will increase our understanding of the biology of indolent and aggressive prostate cancers, and may lead to the development of novel treatments which can modify their progression. This evidence concerns the gene AR and prostate cancer.